Mereo BioPharma Group plc (MREO)
$0.35-7.89%Close
BUYRECOVERY · day 2
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $56M
- Beta
- 0.30
- P/E (TTM)
- -1.92
- Short % float
- 1.68%
- Days to cover
- 1.3
- SI change
- -12.9%
- 1W
- -7.89%
- 1M
- +45.83%
- vs SPY 1W
- -9.06%
- vs SPY 1M
- +42.84%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on MREO?
- LOPJLB’s latest quantitative signal on Mereo BioPharma Group plc (MREO) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is MREO in?
- Mereo BioPharma Group plc (MREO) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Mereo BioPharma Group plc (MREO) do?
- Mereo BioPharma Group plc, a London-based biopharmaceutical firm established in 2015, specializes in developing and commercializing innovative therapies for oncology and rare conditions. Operating both in the United Kingdom and internationally, the company boasts a diverse product pipeline. Its primary oncology asset, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor, is presently unde…